EZZ Life Science Holdings Limited (ASX:EZZ)
0.3600
+0.0100 (2.86%)
Oct 9, 2026, 4:10 PM AEST
EZZ Life Science Holdings Balance Sheet
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Assets
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Cash & Equivalents | 9.72 | 20.85 | 19.02 | 13.83 | 10.46 |
Short-Term Investments | 1.16 | 0.89 | 0.56 | 0.73 | - |
Cash & Short-Term Investments | 10.89 | 21.74 | 19.58 | 14.56 | 10.46 |
Cash Growth | -49.93% | 11.04% | 34.50% | 39.11% | 18.20% |
Accounts Receivable | 4.81 | 4.47 | 2.56 | 1.32 | 2.28 |
Other Receivables | 1.62 | 0.09 | 0.11 | 0.07 | 0.01 |
Receivables | 6.43 | 4.56 | 2.67 | 1.39 | 2.29 |
Inventory | 4.02 | 2.43 | 1.4 | 0.85 | 0.31 |
Prepaid Expenses | 4.62 | 4.31 | 1.26 | 0.21 | - |
Other Current Assets | - | - | - | - | 0.9 |
Total Current Assets | 25.95 | 33.04 | 24.91 | 17.01 | 13.97 |
Property, Plant & Equipment | 0.96 | 0.89 | 0.62 | 0.6 | 0.15 |
Other Intangible Assets | 0.03 | 0.03 | 0.02 | 0.02 | 0.02 |
Long-Term Deferred Tax Assets | 0.7 | - | - | 0.01 | 0.13 |
Total Assets | 27.64 | 33.96 | 25.55 | 17.64 | 14.27 |
Liabilities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Accounts Payable | 2.05 | 3.46 | 2.73 | 2.16 | 2.39 |
Accrued Expenses | 0.08 | 0.07 | 0.04 | 0.03 | 0.04 |
Current Portion of Leases | 0.35 | 0.3 | 0.12 | 0.35 | 0.1 |
Current Income Taxes Payable | - | 1.47 | 1.16 | 0.29 | 0.24 |
Other Current Liabilities | 0.5 | 0.42 | 0.12 | 0.09 | 0.04 |
Total Current Liabilities | 2.98 | 5.73 | 4.18 | 2.93 | 2.82 |
Long-Term Leases | 0.12 | - | - | 0.12 | - |
Pension & Post-Retirement Benefits | 0.04 | - | - | - | - |
Long-Term Deferred Tax Liabilities | - | 0.15 | 0.05 | - | 0.06 |
Total Liabilities | 3.15 | 5.87 | 4.23 | 3.06 | 2.88 |
Shareholders' Equity
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Common Stock | 11.4 | 8.74 | 6.85 | 6 | 5.82 |
Retained Earnings | 13.07 | 19.32 | 14.45 | 8.58 | 5.56 |
Comprehensive Income & Other | 0.02 | 0.03 | 0.02 | 0 | - |
Shareholders' Equity | 24.49 | 28.09 | 21.32 | 14.58 | 11.39 |
Total Liabilities & Equity | 27.64 | 33.96 | 25.55 | 17.64 | 14.27 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Total Debt | 0.48 | 0.3 | 0.12 | 0.48 | 0.1 |
Net Cash (Debt) | 10.41 | 21.44 | 19.46 | 14.08 | 10.36 |
Net Cash Growth | -51.45% | 10.18% | 38.19% | 35.89% | 18.07% |
Net Cash Per Share | 0.22 | 0.46 | 0.45 | 0.33 | 0.24 |
Filing Date Shares Outstanding | 47.07 | 47.17 | 44.41 | 42.71 | 42.76 |
Total Common Shares Outstanding | 47.07 | 47.17 | 44.41 | 42.71 | 42.76 |
Working Capital | 22.97 | 27.31 | 20.73 | 14.07 | 11.16 |
Book Value Per Share | 0.52 | 0.60 | 0.48 | 0.34 | 0.27 |
Tangible Book Value | 24.47 | 28.06 | 21.3 | 14.56 | 11.37 |
Tangible Book Value Per Share | 0.52 | 0.59 | 0.48 | 0.34 | 0.27 |
Machinery | 0.39 | 0.36 | 0.34 | 0.17 | 0.1 |
Leasehold Improvements | 0.5 | 0.5 | 0.28 | 0.03 | - |